Bromocriptine for the treatment of peripartum cardiomyopathy

Circulation

Volumn 121, Issue 13, 2010, Pages 1463-1464

  Elkayam, Uri ^a   Goland, Sorel ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b KAPLAN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; CARVEDILOL; DIGOXIN; DIURETIC AGENT; ENALAPRIL; IMMUNOGLOBULIN; PENTOXIFYLLINE;

CARDIOMYOPATHY; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; OXIDATIVE STRESS; PERIPARTUM CARDIOMYOPATHY; PREGNANCY; PRIORITY JOURNAL; TREATMENT OUTCOME;

BROMOCRIPTINE; CARDIOMYOPATHIES; FEMALE; HORMONE ANTAGONISTS; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR;

EID: 77950868436     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIR.0b013e3181db2f07     Document Type: Editorial

References (22)

1. Sliwa K, Fett J, Elkayam U. Current understanding of the epidemiology, etiology, clinical profile, and management of PPCM. Lancet. 2006;368: 687-693.
2. Elkayam U, Akhter MW, Singh H, Khan S, Bitar M, Hameed A, Shotan A. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation. 2005;111: 2050-2055. (Pubitemid 40577899)
3. Mielniczuk LM, Williams K, Davis DR, Tang A, Lemery R, Green MS, Gollob MH, Haddad H, Birnie D. Frequency of peripartum cardiomyop-athy. Am J Cardiol. 2006;97:1765-1768.
4. Goland S, Modi K, Bitar F, Janmohamed M, Mirocha J, Czer L, Illum S, Hatamizadeh P, Elkayam U. Clinical profile and predictors of complications in peripartum cardiomyopathy. J Card Fail. 2009;15:645-650.
5. Brar SS, Khan SS, Sandhu GK, Jorgensen MB, Parikh N, Hsu JW, Shen A. Incidence, mortality, racial differences in peripartum cardiomyopathy. Am J Cardiol. 2007;100:302-304. (Pubitemid 47041992)
6. Amos AM, Jaber WA, Russell SD. Improved outcomes in peripartum cardiomyopathy with contemporary. Am Heart J. 2006;152:509-513.
7. Modi KA, Illum S, Jariatul K, Caldito G, Reddy P. Poor outcome of indigent patients with peripartum cardiomyopathy in United States. Am J Obstet Gynecol. 2009;201:171-172.
8. Sliwa K, Förster O, Libhaber E, Fett J, Sundstrom JB, Hilfiker-Kleiner D, Ansari A. Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur Heart J. 2006;27:441-446. (Pubitemid 43209169)
9. Fett JD, Sannon H, Thélisma E, Sprunger T, Suresh V. Recovery from severe heart failure following peripartum cardiomyopathy. Int J Gynaecol Obstet. 2009;104:125-127.
10. Demakis JG, Rahimtoola SH, Sutton GC, Medows WR, Szanto PB, Tobin JR, Gunnar RM. Natural course of peripartum cardiomyopathy. Circulation. 1971;44:1053-1061.
11. Bozkurt B, Villaneuva F, Holubkov R, Tokarczyk T, Alvarez RJ Jr, MacGowan GA, Murali S, Rosenblum WD, Feldman AM, McNamara DM. Intravenous immune globulin in the therapy of peripartum cardio-myopathy. J Am Coll Cardiol. 1999;34:177-180.
12. Sliwa K, Skudicky D, Bergemann A, Candy G, Puren A, Sareli P. Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1. J Am Coll Cardiol. 2000;35:701-705. (Pubitemid 30167027)
13. Sliwa K, Skudicky D, Candy G, Bergmann A, Hopley M, Sareli P. The addition of Pentoxiphylline to conventional therapy improves outcome in patients with peripartum cardiomyopathy. Eur J Heart Fail. 2002;4: 305-309. (Pubitemid 35190355)
14. Sliwa K, Blauwet L, Tibazarwa K, Libhaber E, Smedema J-P, Becker A, McMurray J, Yamac H, Labidi S, Struhman I, Hilfiker-Kleiner D. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation. 2010;121: 1465-1473.
15. Hilfiker-Kleiner D, Kaminski K, Podewski E, Bonda T, Schaefer A, Sliwa K, Forster O, Quint A, Landmesser U, Doerries C, Luchtefeld M, Poli V, Balligand JL, Desjardins F, Ansari A, Struman I, Nguyen N, Zschemisch NH, Klein G, Heusch G, Schulz R, Hilfiker A, Drexler H. A cathepsin D-cleaved 16kDa form of prolactin mediates postpartum car-diomyopathy. Cell. 2007;128:589-600.
16. Hilfiker-Kleiner D, Meyer G, Schieffer E, Goldmann B, Podewski G, Struman I, Fischer P, Drexler H. Recovery from postpartum cardiomy-opathy in 2 patients by blocking prolactin release with bromocriptine. J Am Coll Cardiol. 2007;50:2354-2356.
17. Habedank D, Kühnle Y, Elgeti T, Dudenhausen JW, Haverkamp W, Dietz R. Recovery from peripartum cardiomyopathy after treatment with bro-mocriptine. Eur J Heart Fail. 2008;10:1149-1151.
18. Katz M, Kroll D, Pak I, Osimoni A, Hirsch M. Puerperal hypertension, stroke and seizures after suppression of lactation with bromocriptine. Obstet Gynecol. 1985;66:822-823.
19. Dutt S, Wong F, Spurway JH. Fatal myocardial infarction with bro-mocriptine for postpartum lactation suppression. Aust N Z J Obstet Gynaecol. 1998;38:116-117. (Pubitemid 28077511)
20. Duran N, Günes H, Duran I, Biteker M, Ozkan M. Predictors of prognosis in patients with peripartum cardiomyopathy. Int Gynaecol Obstet. 2008; 101:137-140.
21. Chapa JB, Heiberger HB, Weinert L, DeCara J, Lang RM, Hibbard JU. Prognostic value of echocardiography in peripartum cardiomyopathy. Obstet Gynecol. 2005;105:1303-1308. (Pubitemid 40734261)
22. Hu Cl, Li Yb, Zhang JM, Chen JB, Liu J, Tang YH, Tang QZ, Huang CX. Troponin T measurement can predict persistent left ventricular dysfunction in peripartum cardiomyopathy. Heart. 2007;93:488-490. (Pubitemid 46631518)